130 related articles for article (PubMed ID: 9237071)
1. NSAIDs, Barrett's oesophagus and adenocarcinoma prevention.
Vainio H; Morgan G
Eur J Cancer Prev; 1997 Apr; 6(2):200. PubMed ID: 9237071
[No Abstract] [Full Text] [Related]
2. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
Tsibouris P; Hendrickse MT; Isaacs PE
Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
5. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
Morgan G
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
[No Abstract] [Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
Wang F; Lv ZS; Fu YK
Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
[TBL] [Abstract][Full Text] [Related]
7. Medical treatment of Barrett's esophagus: can it prevent cancer?
Sampliner RE
Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
[TBL] [Abstract][Full Text] [Related]
8. Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option?
Fennerty MB; Triadafilopoulos G
Am J Gastroenterol; 2001 Aug; 96(8):2302-5. PubMed ID: 11513166
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
Morris CD; Byrne JP; Armstrong GR; Attwood SE
Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
Vaughan TL; Dong LM; Blount PL; Ayub K; Odze RD; Sanchez CA; Rabinovitch PS; Reid BJ
Lancet Oncol; 2005 Dec; 6(12):945-52. PubMed ID: 16321762
[TBL] [Abstract][Full Text] [Related]
11. Immortal person-time bias in relation to the use of nonsteroidal anti-inflammatory drugs and statins in the prevention of esophageal cancer in patients with Barrett's esophagus.
Azoulay L; Suissa S
Gastroenterology; 2012 May; 142(5):e20-1; author reply e21. PubMed ID: 22449575
[No Abstract] [Full Text] [Related]
12. Barrett's esophagus-emerging concepts and controversies.
Schuchert MJ; Luketich JD
J Surg Oncol; 2007 Mar; 95(3):185-9. PubMed ID: 17323330
[No Abstract] [Full Text] [Related]
13. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
14. [Revision needed of follow-up policy for Barrett's esophagus].
Giard RW; Coebergh JW; Ouwendijk RJ
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
[TBL] [Abstract][Full Text] [Related]
15. Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?
Fennerty MB
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S30-7. PubMed ID: 12478242
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention in Barrett's esophagus: A pill a day?
Jankowski JA; Hooper PA
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):155-70. PubMed ID: 21112505
[TBL] [Abstract][Full Text] [Related]
17. [Barrett's oesophagus: place of antireflux surgery].
Mabrut JY; Baulieux J
Ann Chir; 2006 Mar; 131(3):177-82. PubMed ID: 16527242
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
Gupta RA; DuBois RN
J Natl Cancer Inst; 2002 Mar; 94(6):406-7. PubMed ID: 11904306
[No Abstract] [Full Text] [Related]
19. Surgery or ablation therapy for HGD in patients with Barrett's esophagus?
Eloubeidi MA
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1180. PubMed ID: 18854228
[No Abstract] [Full Text] [Related]
20. Should we worry about the length of Barrett's esophagus?
Shaheen NJ
Gastrointest Endosc; 2005 Nov; 62(5):682-5. PubMed ID: 16246679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
